DIRS.INFO The most relevant business & tech news

☆ Morning-after pill sales surge online, telehealth companies say, as women prepare for second Trump term
▼ + stars: | 2024-11-12 | by ( Jacqueline Howard | ) edition.cnn.com time to read: +6 min

At Wisp, which offers two types of emergency contraception online, sales of those medications went up about 1,000% in just one day after Tuesday’s election. “We are seeing women actually stockpile emergency contraception pills,” Cepak said. “When you attack one piece of reproductive health care, it really has a ripple effect,” Friedrich-Karnik said. “People who need abortion care often also at some point need contraception, and people who need contraception might eventually need maternal health care,” she said. “People’s lives are fluid like that, and this care is fluid, and you can’t attack one piece of reproductive health care without really impacting the whole range of care that people need.”

Persons: Donald Trump, Trump, Monica Cepak, “, ” Cepak, ”, Cynthia Plotch, it’s, ” Plotch, That’s what’s, It’s, ’ ”, Clayton Alfonso, ‘ I’ve, ’ ” Alfonso, Court’s Dobbs, Roe, Wade, Dr, Sanjay Gupta, Amy Friedrich, Karnik, ” Friedrich Organizations: CNN —, “, Winx, Duke Health, American College of Obstetricians, Trump, Heritage Foundation, Republican, CNN, CNN Health, Guttmacher Institute Locations: United States, North Carolina

☆ Healthcare investors are torn on Trump's second term
▼ + stars: | 2024-11-09 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +11 min

While many tech VCs are optimistic about Trump's second term, some healthcare investors feel stuck. AdvertisementThe lower corporate taxes and deregulation a second Trump term could promise are already amplifying public market optimism. She could be removed as the FTC's head early in Trump's second term — and with relaxed M&A regulations, "anything is possible," said What If Ventures founder Stephen Hays. SOPA Images/Contributor/Getty ImagesMedicaid could also be targeted in Trump's second term. A boon for healthcare AI and Medicare AdvantageTrump's victory could have a positive impact on several big areas of healthcare investment.

Persons: —, Donald Trump's, Trump, He's, he'll, Robert F, Kennedy Jr, Trump's, Michael Greeley, Rebecca Noble, Tesla, JP Morgan Chase, Maven, Omada, Sean Duffy, Lina Khan, Stephen Hays, James Leynse, VCs, Carli Sapir, Jordan Nof, Greeley, Shiv Rao, Kennedy Jr's, Chrissy Farr, Phelps, Phillips, Farr Organizations: Trump, Service, Food and Drug Administration, Centers for Disease Control, Biden, Flare Capital Partners, Getty, Healthcare, Health, Cigna, Humana . Bloomberg, Federal Trade Commission, Investors, Business, Amboy Street Ventures, Tusk Venture, Senate, Affordable, Coalition for Health, Mayo Clinic, Johns Hopkins, Microsoft, Alignment Healthcare, Scrub Locations: Trump's Florida, Tuesday's, Trump's, Boston, America

☆ 14 earnings reports and major economic data will be the stock market movers this week
▼ + stars: | 2024-10-27 | by ( Zev Fima | ) www.cnbc.com time to read: +15 min

The Street is looking for Stanley Black & Decker sales of $3.8 billion in the third quarter and earnings per share (EPS) of $1.05. The Street is looking for Linde sales of $8.35 billion in the third quarter and EPS of $3.89. In addition to the headline results and forward guidance, overall organic sales growth and data center energy power demand will be focus items for investors. The Street is looking for sales of $94.47 billion in its fiscal fourth quarter and EPS of $1.55. The Street is looking for Coterra sales of $1.3 billion in the third quarter and EPS of 34 cents.

Persons: That's, It's, Stanley Black, Decker, we're, We're, Eli Lilly, Lilly, Amy Hood's, Brian Niccol, Wednesday's, Linde, it's, we'll, Phillips, Horton, Kraft Heinz, SIRI, Estee Lauder, BUD, Cardinal Health, Jim Cramer's, Jim Cramer, Jim, Stephanie Keith Organizations: Nasdaq, Dow, Fed, PCE, YouTube, Justice, AMD, GE Healthcare, Reality Labs, Microsoft, Management, Starbucks, U.S, Presidential, Linde, Apple Intelligence, Amazon, Services, Coterra Energy, WM, Cadence Design Systems, Labor, PayPal, BP, Pfizer, Royal Caribbean Cruises, JetBlue, HSBC, Devices, Grill, Electronic Arts, EA, Gross, Caterpillar, Brinker International, AFortive Corporation, Illinois Tool, Coinbase, eBay, EBAY, Booking Holdings, MGM Resorts, MGM, Bausch Health, LIN, Merck, ConocoPhillips, Mastercard, Altria, Cruise, Myers Squibb, Comcast, Mobileye, Cheniere Energy, Regeneron Pharmaceuticals, Anheuser, Busch InBev, Intel, United States Steel, Juniper Networks, Chevron, Exxon Mobil, Dominion Energy, Charter Communications, LyondellBasell Industries, Cardinal, Jim Cramer's Charitable, CNBC, New York Stock Exchange, Getty Locations: Eaton, Corning, Illinois, Bristol, New York City

☆ Young men are getting testosterone boosts to feel stronger, sharper, and anxiety-free
▼ + stars: | 2024-10-26 | by ( Andréa Becker | ) www.businessinsider.com time to read: +19 min

He had low testosterone levels, in the range of 219 to 239 nanograms per deciliter. Take Alexis Ohanian, the 41-year-old Reddit cofounder and Serena Williams' husband, who recently posted on X about his (relatively high) testosterone levels. RoWhen LaSara's cofounder John Snedegar opened up his brick-and-mortar men's health clinic in 2017, "nobody" was specializing in men's sexual health, he said. But he typically recommends lifestyle changes, like more exercise, eating better, and getting good sleep, which all naturally help to boost testosterone levels. Researchers such as Berumen worry the branding of men's health clinics prop up impossible standards of manhood.

Persons: Kade, unmotivated, LaSara, Alexis Ohanian, Bryan Bedder, Serena Williams, Joe Rogan, Dax Shepard, it's, Peter Conrad said, endocrinologists, Charles, Édouard Brown, —, Dr, Justin Houman, John Snedegar, Evan Miller, what's, Justin Dubin, Derek, Dana, he's, Houman, Dubin, Snedegar, Gwen Berumen, Berumen Organizations: LaSara, TRT, Ro, CDC, T Center, Men's Health, ESPN, Telltale, Clinic, University of Texas, American Psychological Association, Miami Locations: Idaho, Florida, Cedars, Sinai, Los Angeles, New York City, LaSara, Texas, Miami , Florida, Southern California, California, Miami, bricklayers, Austin

☆ 'The million-dollar question of this election': Women's health startups are confronting a shifting legal landscape
▼ + stars: | 2024-10-22 | by ( Melia Russell | Rebecca Torrence | ) www.businessinsider.com time to read: +14 min

Founders of women's health startups feel doubly invested in this election, one of the closest presidential races of the century. They said another Trump victory creates uncertainty for reproductive health startups, from period trackers to online abortion clinics to embryo banks. For startup Julie, the legal status of emergency contraception is the "million dollar question of this election," said Amanda E/J Morrison. Trump's waffling on reproductive rights has put founders of women's health startups on notice. For some founders of women's health startups, this election is more than a political contest; it has ramifications for their livelihoods.

Persons: Julie, Amanda E, J Morrison, Morrison, Lily, Trump, We're, —, Kamala Harris, Trish Costello, Mika Eddy, Eddy, Samuel Corum, Jane, Roe, Wade, Hey Jane, Carli Sapir, Sapir, Donald Trump, Mark Wilson, Flo, Deena Shakir, Lauren Berson Sugarman, Berson, Alice Zheng, Zheng, Julie's, Dobbs, TikTok influencers, Julie swag, Julie Julie's, It's, Melia Russell, Rebecca Torrence Organizations: Suffolk University, Trump, Getty, Amboy Ventures, White, Lux Capital, Maven, Sciences, Vitra Labs, Investors, Walmart, JAMA, Business Locations: New York, Boston, Texas, California, we're, Roe America, Alabama

☆ Exclusive: Diabetes startup Omada Health has confidentially filed its S-1 to go public
▼ + stars: | 2024-10-02 | by ( Rebecca Torrence | Ben Bergman | ) www.businessinsider.com time to read: +4 min

Diabetes startup Omada Health has confidentially filed its S-1 for an IPO, BI has learned. Fellow healthcare startup Hinge Health has hired banks as it prepares to confidentially file its S-1. AdvertisementRumors about diabetes startup Omada Health's public market debut have been swirling for years. Omada Health confidentially filed its S-1 this summer to go public, according to one person with knowledge of the transaction. After 20 healthcare startups went public in 2021, only one healthcare company went public the following year — Akili Interactive, which sold for $34 million this July.

Persons: —, Health confidentially, It's, Sean Duffy, Morgan Stanley, Cameron Lester, Ben Narasin, Duffy, Omada Organizations: BI, Service, Health, Lyra, Tempus, Jefferies, Venture, Amazon

☆ Insider Today: Austin's genius housing fix
▼ + stars: | 2024-09-28 | by ( Joi-Marie Mckenzie | ) www.businessinsider.com time to read: +7 min

This week's dispatchThe high cost of weight-loss drugsiStock; Rebecca Zisser/BIWhy are two popular weight-loss drugs — Wegovy and diabetes medication Ozempic — so expensive in the US? Patients also bargain-hunt for cheaper weight-loss drugs online, or try to use manufacturer-issued coupons. See the full listiStock; Rebecca Zisser/BIDeals we loveCalling all Madewell shoppers: The bi-annual Madewell Insiders sale is here with 25% off almost everything full-price and an additional 40% off sale. The bi-annual Madewell Insiders sale is here with 25% off almost everything full-price and an additional 40% off sale. The Insider Today team: Dan DeFrancesco, deputy editor and anchor, in New York City.

Persons: —, you've, Shailene Woodley, George Clooney, Rebecca Zisser, Ozempic, Lars Fruergaard Jorgensen, Sen, Bernie Sanders, it's, Gabby Landsverk, Ro, Henry Meds, Eli Lilly, Stefania Pelfini, Jenny Chang, Rodriguez, BI Marie, Mangin, Yellowstone Joey Hadden, Jackson, Wyoming's, Natalie Ammari, Zers, Austin, Tyler Le, Dan DeFrancesco, Jordan Parker Erb, Lisa Ryan, Amanda Yen, Grace Lett Organizations: Business, Service, Novo Nordisk, Federal Trade Commission, FDA, copycats, BI, Yellowstone, Austin, Lone Star, Disney, Pixar, British, Netflix, Insiders Locations: Washington ,, Germany, New York City, New York, Chicago

☆ A doctor shares how his patients are trying to afford weight-loss drugs — and what happens if they can't
▼ + stars: | 2024-09-27 | by ( ) www.businessinsider.com time to read: +4 min

The high price of weight-loss drugs is frustrating for patients who can't access them, a doctor said. Patients struggle to afford these drugs, leading to cycling, rationing, or using risky alternatives. AdvertisementPharmaceutical companies are facing a new wave of criticism for the high price of groundbreaking weight-loss drugs. The latest generation of these class of drugs, medications like Ozempic, Wegovy, Mounjaro, and Zepbound, are once-weekly injections. The competitive pressure will also help drive prices lower as companies aim to attract consumers back to their brand with cheaper options for weight-loss drugs.

Persons: —, Dr, Christopher McGowan, McGowan, that's, they've, Ted Kyle, Kyle Organizations: Service, Pharmaceutical, FDA

☆ FTC sues drug middlemen for allegedly inflating insulin prices
▼ + stars: | 2024-09-20 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen use practices that boost their profits while "artificially" inflating costs for patients. It comes three days after Express Scripts sued the FTC, demanding that the agency retract its allegedly "defamatory" July report that claimed that the PBM industry is hiking drug prices. It also alleges that PBMs favor those high-list-price insulins even when more affordable insulins with lower list prices become available. President Joe Biden's signature Inflation Reduction Act has capped insulin prices for Medicare beneficiaries at $35 per month. The FTC said it remains "deeply troubled" by the role insulin manufacturers play in higher list prices, arguing that they inflate prices in response to PBMs' demands for higher rebates.

Persons: Lina Khan, UnitedHealth, drugmakers Eli Lilly, Caremark, PBMs, Rahul Rao, Rao, Joe Biden's, Biden, Eli Lilly, Eli Lilly's Organizations: Federal Trade Commission, CVS, Cigna's, FTC, Sanofi, Novo Nordisk, Express, Competition Locations: Rayburn, Washington ,, U.S, drugmakers, FTC's

☆ A General Catalyst-backed startup is mass-buying virtual care tech from big players like Walmart. Here's why Fabric is still betting on telehealth.
▼ + stars: | 2024-09-17 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +6 min

Read previewHealthtech startup Fabric launched out of stealth in March 2023 to help patients get care faster and automate administrative work for providers. In June, Fabric bought Walmart's virtual care business, MeMD, after the retailer announced it would shutter its 51 health clinics. MeMD was Fabric's third acquisition — the startup previously bought asynchronous virtual care platform Zipnosis from Bright Health, as well as generative AI startup Gyant. The startup has acquired TeamHealth VirtualCare, the virtual care business inside giant physician practice group TeamHealth, Business Insider has learned exclusively. While virtual care saw a tsunami of VC interest during the pandemic, investors and healthcare companies alike are now pulling back.

Persons: —, it's, MeMD, TeamHealth VirtualCare, UnitedHealth Group's Optum, Aniq Rahman, Rahman, we've, Hemant Taneja, Commure, We've, Moat Organizations: Service, Fabric, Bright Health, Business, Google Ventures, Salesforce Ventures, General Catalyst, Bright, Walmart, Vast Ventures, Oracle Locations: Florence

☆ Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
▼ + stars: | 2024-09-12 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +5 min

Digital health company Noom on Thursday announced it will offer a compounded GLP-1 drug as part of a new weight loss product that starts at $149. Noom has offered weight loss programs for years, and consumers can already try to access those branded medications through its platform. Compounded GLP-1 medications are typically much cheaper than their branded counterparts. Most insurance plans cover GLP-1s when they are used to treat diabetes, but coverage of the weight loss drugs is less widespread. Consumers can get started with the Noom GLP-1 RX program by filling out an intake form on the website.

Persons: Wegovy, Noom, Geoff Cook, Cook, Dr, Adonis Saremi, They'll Organizations: CNBC, U.S . Food, Drug Administration, FDA Locations: U.S, United States

☆ Women face bias and disparities in healthcare. Digital tools could help meet their needs.
▼ + stars: | 2024-09-06 | by ( Sarah Sloat | ) www.businessinsider.com time to read: +8 min

Historically, women's healthcare has been impaired by challenges like bias and a lack of specialized providers. For years, healthcare systems weren't designed for women, and there are still gaps in research and treatments for women's health issues. AdvertisementWith this reality in mind, Joanna Strober cofounded Midi Health, a website designed to help people experiencing menopause and perimenopause access specialists. Interventions can range from lifestyle coaching to prescription medication, and Midi providers can refer patients to in-person treatments when needed. Midi Health is on its way toward doing that; the company closed a $60 million Series B round in April.

Persons: Ashlee Wisdom, Wisdom, Smisha Agarwal, Agarwal, they're, Joanna Strober, Strober Organizations: New York University, Health, Center for Global Digital Health Innovation, Johns Hopkins University, Women's Health, US National Institutes of Health, Midi Health, Midi, Silicon Valley Bank Locations: Black

The direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine whether their insurance covers a buzzy class of weight loss and diabetes drugs called GLP-1s. Ro said nearly half of the company's patients have some form of insurance coverage for a GLP-1, according to its customer data. Ro said it hopes its new tool can help patients understand their coverage options so they can decide how to pursue weight loss. The digital health company may benefit too, as it could drive some patients to join the company's GLP-1 program. It includes 24/7 messaging, one-on-one coaching with nurses and help with navigating insurance coverage.

Persons: Ro, Zachariah Reitano Organizations: Novo Nordisk, CNBC Locations: U.S

☆ More public healthcare companies will be taken private. Here's what PE firms are betting on.
▼ + stars: | 2024-08-12 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +7 min

Read previewRevenue cycle management company R1 RCM just announced its acquisition by two private equity firms for a whopping $8.9 billion — signaling a long-awaited resurgence of big healthcare deals. Private equity's return to the sceneThe debt market is finally correcting for the types of deals healthcare companies have been waiting for. Revenue cycle management has long been a hot area for private equity firms. AdvertisementSpringer said she thinks private equity firms are "very unlikely to buy a care delivery company in this environment." Sen. Markey introduced the Health Over Wealth Act in July that would limit private equity investment in healthcare providers.

Persons: —, Augmedix, Altaris, hasn't, dealmakers, David Marks, They're, Thad Davis, haven't, Davis, Tanay Tandon, Commure, Athelas, it's, Rebecca Springer, we'll, Shiv Rao, Abridge Springer, she'd, Springer, Steward, Sen, Markey, Brian Snyder, Knight's Marks, I've, Marks Organizations: Service, Business, Holland &, Leerink Partners, Epic, Mayo Clinic, Reuters, Holland, FTC

☆ Insider Today: A historic outage
▼ + stars: | 2024-07-21 | by ( Matt Turner | ) www.businessinsider.com time to read: +5 min

download the appSign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. Since then:This story is available exclusively to Business Insider subscribers. You can get the latest on what the political turmoil might mean for businesses, the economy, and markets right here or by downloading the Business Insider app. This week's dispatchMaster/Getty, Yevgeniy Sambulov/Getty, Tyler Le/BIA historic outageComputers at Australian retailer Woolworths froze with the blue screen of death. An update gone wrong from a single company many hadn't heard of before Friday morning brought retailers, banks, hospitals, production lines, and airlines to a halt.

Persons: —, It's, Donald Trump, Yevgeniy Sambulov, Tyler Le, Cash, Tesla, Crowdstrike, Jenny Chang, Rodriguez, Slack, de Haro, Gen Z, Rebecca Zisser, Mickey Mouse, Lizzie McGuire, Hannah Montana Organizations: Service, Business, Woolworths, Airline, Microsoft, Getty, Workers, BI Tech, Big Tech, Disney, YouTube Locations: Japan, Alaska

☆ Online Health Providers Are Making Money on Young Men's Sense of Shame
▼ + stars: | 2024-07-18 | by ( Emily Stewart | ) www.businessinsider.com time to read: +11 min

The pandemic accelerated the rise of telehealth, which these DTC companies are a part of both culturally and legally. Hims & Hers Health has a market cap of over $4 billion. Those at the forefront of the DTC health revolution have American guys right where they want them: insecure, on edge, and ready to open their wallets. Plenty of doctors have sounded the alarm about DTC telehealth companies, and some firms have gotten into legal trouble, too. For all the issues with DTC companies, it's fair to note that traditional healthcare settings are far from perfect.

Persons: Paul, he'd, who's, He's, doesn't, Nobody, didn't, Matthew McCoy, what's, Ashwini Nagappan, Joshua Halpern, Halpern, Nagappan, McCoy, Hims, —, you've, They're, men's, Ro, Emily Stewart Organizations: View Research, Department of Medical, University of Pennsylvania, UCLA's Fielding School of Public Health, Northwestern University's Feinberg School of Medicine, telemedicine, of Justice, Business Locations: Hims

☆ Huma, a London-based healthcare startup, just raised $80 million to offer new AI services using this 11-slide pitch deck
▼ + stars: | 2024-07-16 | by ( Callum Burroughs | ) www.businessinsider.com time to read: +2 min

Read previewHuma, an AI digital healthcare company, has raised $80 million in Series D funding. "AI is core to how we build scalable digital health solutions," Huma CEO Dan Vahdat, told Business Insider. "It is a challenging environment for digital health companies in general, particularly with the public markets being down," Vahdat added. The company's $80 million Series D funding round was raised by new and existing investors such as AstraZeneca, Hat Technology Fund 4 by HAT SGR, HV Fund by Hitachi Ventures, and Leaps by Bayer. Check out Huma's 11-slide Series D pitch deck below:

Persons: —, Dan Vahdat, Huma, Sifted, Vahdat Organizations: Service, Business, Bayer, AstraZeneca, Hat Technology, HAT, Hitachi Ventures Locations: Swedish

Joe Raedle | Getty ImagesAn Express Scripts spokesperson said "the prices of insulin and other medicines are set by their manufacturers, who have raised list prices repeatedly." The FTC's investigation into insulin prices also examines drugmakers, but it is unclear whether they will be named in the upcoming lawsuits, Politico reported, citing sources. Eli Lilly , French drugmaker Sanofi and Danish pharmaceutical company Novo Nordisk control roughly 90% of the U.S. insulin market. They also create lists of medications – or formularies – that are covered by insurance and reimburse pharmacies for prescriptions. Pharmacist Thomas Jensen looks over a prescription drug at the Rock Canyon Pharmacy in Provo, Utah, on May 9, 2019.

Persons: Lina Khan, Tom Williams, Joe Raedle, Eli Lilly, Sanofi, Thomas Jensen, George Frey Organizations: Trade, Financial Services, General Government, CQ, Inc, Getty, Federal Trade Commission, CNBC, UnitedHealth, CVS, Politico, Novo Nordisk, Pharmacy Locations: Miami , Florida, Danish, U.S, Provo , Utah

☆ Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source says
▼ + stars: | 2024-07-10 | by ( Annika Kim Constantino Mary Catherine Wellons | Annika Kim Constantino | Mary Catherine Wellons | ) www.cnbc.com time to read: +3 min

Joe Raedle | Getty ImagesAn Express Scripts spokesperson said the "prices of insulin and other medicines are set by their manufacturers, who have raised list prices repeatedly." They also create lists of medications — or formularies — that are covered by insurance and reimburse pharmacies for prescriptions. The investigation into insulin prices also examines drugmakers, but it is unclear whether they will be named in the upcoming lawsuits, Politico reported, citing people familiar with the matter. Eli Lilly , French drugmaker Sanofi and Danish pharmaceutical company Novo Nordisk control roughly 90% of the U.S. insulin market. Pharmacist Thomas Jensen looks over a prescription drug at the Rock Canyon Pharmacy in Provo, Utah, on May 9, 2019.

Persons: Lina Khan, Tom Williams, Joe Raedle, PBMs, Eli Lilly, Sanofi, Thomas Jensen, George Frey Organizations: Trade, Financial Services, General Government, CQ, Inc, Getty, Federal Trade Commission, CNBC, UnitedHealth, CVS, FTC, Politico, Novo Nordisk, Pharmacy Locations: Miami, U.S, Danish, Provo , Utah

☆ Tensions mount at troubled mental health startup Cerebral as another investor files a lawsuit
▼ + stars: | 2024-06-17 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +5 min

Read previewThe infighting at mental health startup Cerebral is in full swing after an investor filed a lawsuit alleging another of the company's backers cost Cerebral hundreds of millions of dollars in value. This story is available exclusively to Business Insider subscribers. Access Industries' representative on Cerebral's board, Nami Park, is also an individual defendant in the lawsuit. But after Access filed its lawsuit against WestCap and Cerebral in April, that self-tender never happened, the June suit claims. With that offer buried, SoftBank still occupies one of six seats on Cerebral's board of directors.

Persons: —, WestCap, Len Blavatnik, Nami, WestCap's countersuit, would've, could've, WestCap's, SoftBank Organizations: Service, Access Industries, Business, Industries, WestCap, US Department of Justice, hasn't, Rock Health, Federal Trade Commission, FTC Locations: Delaware

☆ A.D.H.D. Startup Executives Accused of $100 Million Fraud in Adderall Scheme
▼ + stars: | 2024-06-13 | by ( Dani Blum | ) www.nytimes.com time to read: +1 min

Tens of thousands of patients with attention deficit hyperactivity disorder nationwide could face disruptions to their care after two executives of a major telehealth company that distributed A.D.H.D. The Department of Justice announced on Thursday that the chief executive and the clinical president of Done, the telehealth company, had been arrested and accused of participating in a scheme to distribute Adderall and other stimulants for A.D.H.D. to patients who did not need the medications, and to bill insurers for these drugs. The charges come amid ongoing shortages of Adderall and another stimulant, Vyvanse. said that as many as 50,000 patients across the nation who rely on Done or similar telehealth platforms to obtain stimulant medications may be affected.

Persons: General Merrick B, Garland Organizations: of Justice, Centers for Disease Control

☆ Waystar shares slip in Nasdaq debut after digital health company priced IPO in middle of range
▼ + stars: | 2024-06-07 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +2 min

Waystar shares slid about 3% in their Nasdaq debut on Friday, after the health-care payment software vendor priced its IPO in the middle of the expected range. The stock opened at $21 per share, below the IPO price of $21.50 late Thursday. The IPO market has been largely dormant since late 2021 when the extended bull market turned and investors began to worry about a weakening economy. But the broader venture-backed tech market may be beginning to thaw. Health tech company Tempus AI has also issued a preliminary prospectus this year.

Persons: Waystar, Matt Hawkins, CNBC's, JPMorgan Chase, Goldman Sachs Organizations: Nasdaq, Rock Health, Health, ZirMed, JPMorgan, Barclays

Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called GLP-1s amid shortages of those treatments in the U.S. The supply tracker could be a valuable tool for many Americans scrambling to get their hands on GLP-1s, such as Novo Nordisk 's weight loss injection Wegovy and diabetes drug Ozempic. The tracker aims to make GLP-1 supply information more transparent and accessible for everyone, regardless of whether they are enrolled in any of Ro's programs. The tracker is an interactive tool that gives people real-time supply information by drug, dose size and pharmacy location. He added that opening up the tracker to everyone also makes it more likely for both Ro patients and people not enrolled in the company's programs to access GLP-1s.

Persons: Ro, Eli Lilly, Zachariah Reitano, Reitano Organizations: Wednesday, U.S, Novo Nordisk, U.S . Food, Drug Administration, CNBC Locations: U.S

In addition to Wegovy and Ozempic, the GLP-1 class includes Eli Lilly's highly popular weight loss drug Zepbound and diabetes treatment Mounjaro. VanGilder signed up nearly four years ago and started taking the weekly diabetes injection Ozempic specifically for weight loss. The big difference between Calibrate and prior weight loss efforts, VanGilder said, is that she doesn't feel like she's dieting. Calibrate is one of the only companies to regularly release reports detailing the results of its weight loss program. The federal Medicare program by law can't cover weight loss drugs unless the prescription is for another approved health benefit, such as diabetes or cardiovascular health.

Persons: Michael Siluk, Gray Beard, She'd, that's, Beard, wouldn't, She's, Ro, Goldman Sachs, Eli Lilly's, it's, Andrew Dudum, There's, Zachariah Reitano, Reitano, Wegovy, WeightWatchers, Gary Foster, Foster, Oprah Winfrey's, Kim Gradwell, Lee Smith, Jennifer VanGilder, she'd, Jenny Craig, VanGilder, I've, Kristin Baier, Rob MacNaughton, Ro's Reitano, we'd, Eli Lilly, Craig Primack, Primack, Hims, Dudum, We're Organizations: — Novo, UCG, Novo Nordisk, CNBC, Teladoc Health, World Health Organization, Food, WeightWatchers Clinic, Ursinus College, Asset Management Locations: Charlotte , North Carolina, U.S, Dudley , North Tyneside, Britain, Collegeville , Pennsylvania, Hims

☆ These are the 13 mental health startups that could IPO, make acquisitions, or get bought this year, according to analysts
▼ + stars: | 2024-05-15 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +3 min

Modern HealthModern Health provides personalized mental health treatment to employers, including coaching and therapy. Lennox-Miller said it's unlikely Modern Health could snag the same valuation from its last fundraise in a deal today. DeGagne said employer-focused mental health startups such as Modern Health have the potential for more profitable growth with "stickier" recurring revenue models. He said pharmacy giants Walgreens or CVS Health might seek to pick up a mental health asset like Modern Health. In a statement provided by Modern Health, Forrester senior analyst Jonathan Roberts said, "Modern Health is certainly a partner with its finger on the pulse.

Persons: Alyson Watson, Alexander Lennox, Miller, fundraise, DeGagne, Forrester, Jonathan Roberts Organizations: Modern Health, Health, Lennox, BI, Modern, Walgreens, CVS Health, CVS

Search resuls for: "Health Companies"

25 mentions found